| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 1396 |
| 1 | ADALIMUMAB | 1369 |
| 2 | METHOTREXATE | 1248 |
| 3 | ETANERCEPT | 1236 |
| 4 | TOCILIZUMAB | 1072 |
| 5 | INFLIXIMAB | 998 |
| 6 | LEFLUNOMIDE | 996 |
| 7 | PREDNISONE | 933 |
| 8 | LAMOTRIGINE | 900 |
| 9 | ABATACEPT | 785 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MOGAMULIZUMAB-KPKC | 81 | 0.0595 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 446 | 0.0534 |
| 2 | CLINDAMYCIN PHOSPHATE | 189 | 0.0343 |
| 3 | GOLD | 174 | 0.0300 |
| 4 | GOLIMUMAB | 350 | 0.0278 |
| 5 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 15 | 0.0242 |
| 6 | MEXILETINE HYDROCHLORIDE | 10 | 0.0238 |
| 7 | EPINASTINE HYDROCHLORIDE | 26 | 0.0228 |
| 8 | BETAMETHASONE DIPROPIONATE | 142 | 0.0212 |
| 9 | DACOMITINIB | 14 | 0.0187 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 2047 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1962 |
| 2 | Mood Stabilizer [EPC] | 1503 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 1491 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 1314 |
| 5 | Anti-epileptic Agent [EPC] | 1161 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 1081 |
| 7 | Proton Pump Inhibitor [EPC] | 999 |
| 8 | Antirheumatic Agent [EPC] | 997 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 881 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Chemokine Receptor Type 4 Interaction [EPC] | 81 | 0.0595 |
| 1 | Interleukin-5 Antagonist [EPC] | 10 | 0.0145 |
| 2 | Anthracycline Topoisomerase Inhibitor [EPC] | 35 | 0.0144 |
| 3 | Provitamin D2 Compound [EPC] | 343 | 0.0115 |
| 4 | Tricyclic Antidepressant [EPC] | 5 | 0.0104 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 61 | 0.0104 |
| 6 | Antirheumatic Agent [EPC] | 997 | 0.0094 |
| 7 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 881 | 0.0089 |
| 8 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 9 | Aminosalicylate [EPC] | 797 | 0.0079 |